Fact Blog

Business2026.05.21

Nearly 80% of a Major Game Company's Revenue Comes from Recurrent Consumer Spending

On May 21, 2026, Take-Two Interactive, a major U.S. video game company, announced its financial results for fiscal year 2026 (April 2025–March 2026). The company publishes globally popular game franchises, including Grand Theft Auto (GTA) and NBA 2K.

    According to the report, annual net revenue reached approximately US$6.66 billion, an 18% increase from the previous year. Notably, 78% of the company's net revenue came from recurrent consumer spending. Recurrent consumer spending refers to repeated spending by players after purchasing a game or while playing a free-to-play game. Typical examples include purchases of in-game currency, character outfits, items, and additional content. The company's definition also includes revenue from in-game advertising.


Comment from GAME-F

In the past, the video game industry primarily generated revenue through the sale of game software. Today, however, business models increasingly rely on encouraging players to continue playing and to make additional purchases or use paid services within games. While this approach supports ongoing game development and the provision of new content, it also creates a close relationship between players' engagement time, spending behavior, and potentially addictive features of games, on the one hand, and corporate revenue on the other.

    The pursuit of profit by game companies is no different from that of other businesses. Furthermore, purchasing additional content while enjoying a game does not necessarily lead to gaming addiction. However, we need to understand the business models in which continued gameplay and repeated consumer spending support corporate revenue.


References

Take-Two Interactive Software, Inc. (May 21, 2026). Reports Results for Fourth Quarter and Fiscal Year 2026.

https://www.take2games.com/ir/news/take-two-interactive-software-inc-reports-results-fourth-2

Latest Fact Blog


本サイトは、ゲーム行動とその影響に関する一般的な情報提供を目的とし、個別の診断や治療の代わりにはなりません。掲載内容は研究の進展により更新されることがあります。